Skip to content

Clinical trials

Phase 2/3 Heart Failure trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 2/3 Country / region: Canada Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20062
20081
20091
20111
20211
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated3
Recruiting2
Unknown status2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ottawa Heart Institute Research Corporation2
AstraZeneca1
Biotronik, Inc.1
C. T. Lamont Primary Care Research Centre1
Hamilton Health Sciences Corporation1
Merck Sharp & Dohme LLC1
Paracor Medical, Inc1
Queen's University1
University of Calgary1
Viacor1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure11
Pulmonary Disease, Chronic Obstructive2
Ventricular Dysfunction, Left2
Breast Neoplasms1
Diabetes Mellitus1
Heart Diseases1
Hypertension1
Hypotension1
Mitral Valve Insufficiency1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.